CD34+ chimerism analysis for minimal residual disease monitoring after allogeneic hematopoietic cell transplantationAthira Unnikrishnan, Maxim Norkin, Paul Castillo et al.|Leukemia Research|2018Cited by 7
Peripheral Blood CD34+ Specific Donor Chimerism Analysis As an Early Indicator of Disease Relapse After Allogeneic Hematopoietic Stem Cell Transplant in Patients with Myelodysplastic Syndromes and Acute Myelogenous Leukemia.Maxim Norkin, John R. Wingard, Amy Meacham et al.|Blood|2012Cited by 0
C∗08:02/16:02 versus C∗05:01/16:01, ambiguous pairs particularly susceptible to typing errorSteven Goldstein, Mai Ta, Maxim Norkin|Human Immunology|2015Cited by 0